Health
Researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk – ABS-CBN News
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among…
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors – cold viruses used to deliver vaccine material – send some of their payload into the nucleus of cells, where some of the instructions…
-
Noosa News9 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business14 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business12 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025